Pillar Pharmaceuticals I LP 13D and 13G filings for Idera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-08-17 4:30 pm Purchase |
2020-07-13 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals I LP | 1,743,774 19.900% |
1,007,996 (+137.00%) |
Filing |
| 2020-05-06 9:59 pm Purchase |
2020-04-07 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals I LP | 735,777 18.600% |
333,633 (+82.96%) |
Filing |